Lucira Health, Inc.
LHDX · NASDAQ
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |
|---|---|---|---|---|
| Revenue | $93 | $0 | $0 | $0 |
| % Growth | 34,492.9% | – | – | – |
| Cost of Goods Sold | $83 | $2 | $0 | $0 |
| Gross Profit | $10 | -$2 | $0 | $0 |
| % Margin | 11% | -621.6% | – | – |
| R&D Expenses | $40 | $25 | $11 | $8 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $36 | $6 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$1 | -$2 | -$6 | -$4 |
| Operating Expenses | $75 | $28 | $8 | $6 |
| Operating Income | -$65 | -$32 | -$14 | -$10 |
| % Margin | -69.4% | -11,868% | – | – |
| Other Income/Exp. Net | -$0 | -$5 | $5 | $3 |
| Pre-Tax Income | -$65 | -$37 | -$8 | -$7 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$65 | -$37 | -$9 | -$7 |
| % Margin | -69.7% | -13,903.7% | – | – |
| EPS | -1.86 | -1.04 | -0.56 | -0.44 |
| % Growth | -78.8% | -85.7% | -27.3% | – |
| EPS Diluted | -1.86 | -1.04 | -0.56 | -0.44 |
| Weighted Avg Shares Out | 35 | 36 | 15 | 15 |
| Weighted Avg Shares Out Dil | 35 | 36 | 15 | 15 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $4 | $2 | $6 | $4 |
| EBITDA | -$61 | -$30 | -$7 | -$6 |
| % Margin | -65% | -10,966.5% | – | – |